‘Watson’ axed: why CBS pulled the plug on Morris Chestnut drama

The medical mystery drama Watson has officially ended after CBS confirmed its cancellation following two seasons, bringing the story of Dr John Watson to an abrupt close just as major narrative twists were unfolding.

Starring Morris Chestnut in the lead role, the series followed Dr Watson as head of a diagnostic clinic focused on rare medical cases while also dealing with the emotional aftermath of his connection to Sherlock Holmes. The show premiered in January 2025 and built its narrative around case of the week mysteries combined with an ongoing personal storyline involving grief, memory and deception.

CBS announced in March 2026 that both Watson and another series, DMV, would not return for further seasons. According to network leadership, the decision was driven by programming strategy and the need to make room for new content across its schedule. Executives emphasised that all available performance data is reviewed collectively when determining renewals, particularly on a network with a high volume of scripted programming.

The season 2 finale aired on May 3, 2026, serving as the final episode of the series. Titled ‘The Cobalt Fissure’, it concluded with a significant twist involving the long speculated return of Sherlock Holmes, a character portrayed within the series by Robert Carlyle. The reveal that Holmes may have been alive added heightened emotional weight to the ending, which now stands as the show’s conclusion.

Cast members responded to the cancellation with messages of gratitude and disappointment. Morris Chestnut acknowledged the unpredictability of the television industry while thanking fans for their support throughout the show’s run. Other actors, including Inga Schlingmann and Rochelle Aytes, shared reflections on their experiences, highlighting the strong working environment and emotional connection to the series.

Audience reaction has been mixed, with some viewers expressing frustration at the timing of the cancellation, particularly given the unresolved storyline developments introduced in the final episodes. Others noted that broadcast television continues to face increased competition from streaming platforms, which often influence renewal decisions based on broader audience metrics and advertising performance.

Network representatives have stated that decisions like this are part of maintaining a balanced schedule, even when shows have dedicated fan bases. While Watson had a modest viewership presence, it ultimately did not secure long term continuation in CBS’s evolving lineup.

As a result, Watson joins a growing list of recent network dramas ending after short runs, reflecting the increasingly competitive nature of scripted television production. The series leaves behind a compact but twist driven narrative that attempted to reimagine one of literature’s most recognisable characters through a modern medical lens.